HK1017999A1 - Slow-release pharmaceutical formulations containing mizolastin - Google Patents
Slow-release pharmaceutical formulations containing mizolastinInfo
- Publication number
- HK1017999A1 HK1017999A1 HK99102759A HK99102759A HK1017999A1 HK 1017999 A1 HK1017999 A1 HK 1017999A1 HK 99102759 A HK99102759 A HK 99102759A HK 99102759 A HK99102759 A HK 99102759A HK 1017999 A1 HK1017999 A1 HK 1017999A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- mizolastin
- slow
- pharmaceutical formulations
- formulations containing
- release pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pulmonology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Ophthalmology & Optometry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9602662A FR2745500B1 (fr) | 1996-03-04 | 1996-03-04 | Formulations pharmaceutiques a liberation prolongee contenant de la mizolastine |
| PCT/FR1997/000355 WO1997032584A1 (fr) | 1996-03-04 | 1997-02-28 | Formulations pharmaceutiques a liberation prolongee contenant de la mizolastine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1017999A1 true HK1017999A1 (en) | 1999-12-10 |
Family
ID=9489799
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK99102759A HK1017999A1 (en) | 1996-03-04 | 1999-06-30 | Slow-release pharmaceutical formulations containing mizolastin |
Country Status (35)
| Country | Link |
|---|---|
| US (2) | US6165507A (zh) |
| EP (1) | EP0906101B1 (zh) |
| JP (2) | JP2000512617A (zh) |
| KR (1) | KR100369888B1 (zh) |
| CN (1) | CN1112929C (zh) |
| AR (1) | AR006082A1 (zh) |
| AT (1) | ATE219365T1 (zh) |
| AU (1) | AU725494B2 (zh) |
| BG (1) | BG63451B1 (zh) |
| BR (1) | BR9707827A (zh) |
| CA (1) | CA2247405C (zh) |
| CO (1) | CO4780020A1 (zh) |
| CY (1) | CY2293B1 (zh) |
| CZ (1) | CZ291418B6 (zh) |
| DE (1) | DE69713505T2 (zh) |
| DK (1) | DK0906101T3 (zh) |
| EE (1) | EE03511B1 (zh) |
| ES (1) | ES2177942T3 (zh) |
| FR (1) | FR2745500B1 (zh) |
| HK (1) | HK1017999A1 (zh) |
| HU (1) | HU227472B1 (zh) |
| IL (1) | IL126050A (zh) |
| IN (1) | IN187739B (zh) |
| NO (1) | NO315841B1 (zh) |
| NZ (1) | NZ331947A (zh) |
| OA (1) | OA10854A (zh) |
| PL (1) | PL189813B1 (zh) |
| PT (1) | PT906101E (zh) |
| RU (1) | RU2173997C2 (zh) |
| SK (1) | SK282112B6 (zh) |
| TR (1) | TR199801574T2 (zh) |
| TW (1) | TW491711B (zh) |
| UA (1) | UA49004C2 (zh) |
| WO (1) | WO1997032584A1 (zh) |
| ZA (1) | ZA971830B (zh) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002087960A (ja) * | 2000-07-14 | 2002-03-27 | Toyama Chem Co Ltd | 徐放性錠剤 |
| WO2002028181A1 (en) * | 2000-10-02 | 2002-04-11 | Usv Limited | Sustained release pharmaceutical compositions containing metformin and method of its production |
| US7052706B2 (en) | 2001-06-08 | 2006-05-30 | Nostrum Pharmaceuticals, Inc. | Control release formulation containing a hydrophobic material as the sustained release agent |
| US20030181488A1 (en) * | 2002-03-07 | 2003-09-25 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Administration form for the oral application of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester and the salts thereof |
| WO2004078164A1 (en) * | 2003-03-04 | 2004-09-16 | Nostrum Pharmaceuticals, Inc. | Control release formulation containing a hydrophobic material as the sustained release agent |
| DE10337697A1 (de) * | 2003-08-16 | 2005-03-24 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Tablette enthaltend 3-[(2-{[4-(Hexyloxycarbonylamino-imino-methyl)-phenyl-amino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionsäure-ethylester oder dessen Salze |
| JP5295356B2 (ja) | 2008-07-28 | 2013-09-18 | 武田薬品工業株式会社 | 医薬組成物 |
| JP5744412B2 (ja) * | 2010-03-26 | 2015-07-08 | テバ製薬株式会社 | フロセミド製剤 |
| US20140179712A1 (en) | 2012-12-21 | 2014-06-26 | Astrazeneca Ab | Pharmaceutical formulation of n-[5-[2-(3,5-dimethoxyphenyl)ethyl]-2h-pyrazol-3-yl]-4-[(3r,5s)-3,5-dimethylpiperazin-1-yl]benzamide |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4364945A (en) * | 1979-12-13 | 1982-12-21 | Whittle Barry J | Nasal composition for relieving nasal distress |
| US4421736A (en) * | 1982-05-20 | 1983-12-20 | Merrel Dow Pharmaceuticals Inc. | Sustained release diethylpropion compositions |
| US4590062A (en) * | 1984-04-16 | 1986-05-20 | Tech Trade Corp. | Dry direct compression compositions for controlled release dosage forms |
| FR2587029B1 (fr) * | 1985-09-11 | 1987-10-30 | Synthelabo | Derives de benzimidazole, leur preparation et leur application en therapeutique |
| JPH0776172B2 (ja) * | 1986-04-16 | 1995-08-16 | 藤沢薬品工業株式会社 | マトリツクス錠 |
| JPS62283926A (ja) * | 1986-06-02 | 1987-12-09 | Nippon Chemiphar Co Ltd | 塩酸ニカルジピン持続性組成物 |
| DE3812799A1 (de) * | 1988-04-16 | 1989-10-26 | Sanol Arznei Schwarz Gmbh | Oral zu verabreichende pharmazeutische zubereitung mit kontrollierter wirkstofffreisetzung und verfahren zu deren herstellung |
| JP3195391B2 (ja) * | 1991-11-14 | 2001-08-06 | エスエス製薬株式会社 | 徐放性トラピジル錠 |
| US5686105A (en) * | 1993-10-19 | 1997-11-11 | The Procter & Gamble Company | Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery |
| IT1264696B1 (it) * | 1993-07-09 | 1996-10-04 | Applied Pharma Res | Forme farmaceutiche destinate alla somministrazione orale in grado di rilasciare sostanze attive a velocita' controllata e differenziata |
| JPH07112932A (ja) * | 1993-08-27 | 1995-05-02 | Mitsui Toatsu Chem Inc | 徐放性医薬製剤 |
-
1996
- 1996-03-04 FR FR9602662A patent/FR2745500B1/fr not_active Expired - Fee Related
-
1997
- 1997-02-27 TW TW086102425A patent/TW491711B/zh not_active IP Right Cessation
- 1997-02-27 IN IN358CA1997 patent/IN187739B/en unknown
- 1997-02-28 IL IL12605097A patent/IL126050A/en not_active IP Right Cessation
- 1997-02-28 CA CA002247405A patent/CA2247405C/en not_active Expired - Lifetime
- 1997-02-28 EE EE9800275A patent/EE03511B1/xx unknown
- 1997-02-28 US US09/125,810 patent/US6165507A/en not_active Expired - Lifetime
- 1997-02-28 PT PT97907145T patent/PT906101E/pt unknown
- 1997-02-28 CN CN97192804A patent/CN1112929C/zh not_active Expired - Lifetime
- 1997-02-28 EP EP97907145A patent/EP0906101B1/fr not_active Expired - Lifetime
- 1997-02-28 ES ES97907145T patent/ES2177942T3/es not_active Expired - Lifetime
- 1997-02-28 KR KR10-1998-0706802A patent/KR100369888B1/ko active IP Right Grant
- 1997-02-28 AU AU19300/97A patent/AU725494B2/en not_active Expired
- 1997-02-28 CO CO97010841A patent/CO4780020A1/es unknown
- 1997-02-28 DK DK97907145T patent/DK0906101T3/da active
- 1997-02-28 AT AT97907145T patent/ATE219365T1/de active
- 1997-02-28 BR BR9707827A patent/BR9707827A/pt not_active IP Right Cessation
- 1997-02-28 UA UA98084447A patent/UA49004C2/uk unknown
- 1997-02-28 PL PL97328763A patent/PL189813B1/pl unknown
- 1997-02-28 WO PCT/FR1997/000355 patent/WO1997032584A1/fr active IP Right Grant
- 1997-02-28 JP JP09531506A patent/JP2000512617A/ja active Pending
- 1997-02-28 CZ CZ19982791A patent/CZ291418B6/cs not_active IP Right Cessation
- 1997-02-28 RU RU98118019/14A patent/RU2173997C2/ru active
- 1997-02-28 TR TR1998/01574T patent/TR199801574T2/xx unknown
- 1997-02-28 DE DE69713505T patent/DE69713505T2/de not_active Expired - Lifetime
- 1997-02-28 HU HU9902458A patent/HU227472B1/hu unknown
- 1997-02-28 SK SK1210-98A patent/SK282112B6/sk not_active IP Right Cessation
- 1997-03-03 AR ARP970100839A patent/AR006082A1/es active IP Right Grant
- 1997-03-03 ZA ZA9701830A patent/ZA971830B/xx unknown
-
1998
- 1998-08-12 BG BG102692A patent/BG63451B1/bg unknown
- 1998-09-02 NO NO19984035A patent/NO315841B1/no not_active IP Right Cessation
- 1998-09-04 OA OA9800160A patent/OA10854A/fr unknown
- 1998-09-18 NZ NZ331947A patent/NZ331947A/xx not_active IP Right Cessation
-
1999
- 1999-06-30 HK HK99102759A patent/HK1017999A1/xx not_active IP Right Cessation
-
2002
- 2002-08-26 CY CY0200052A patent/CY2293B1/xx unknown
-
2005
- 2005-01-03 US US11/027,680 patent/US20050202089A1/en not_active Abandoned
-
2007
- 2007-03-05 JP JP2007054262A patent/JP2007182451A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EG23826A (en) | Pharmaceutical formulations | |
| GB9713149D0 (en) | Pharmaceutical formulations | |
| ZA953236B (en) | Pharmaceutical formulations | |
| GB9523752D0 (en) | Pharmaceutical formulations | |
| SG79255A1 (en) | Pharmaceutical formulations | |
| ZA951781B (en) | Pharmaceutical formulations | |
| ZA982872B (en) | Pharmaceutical formulation | |
| CY2293B1 (en) | Slow-release pharmaceutical formulations containing mizolastin | |
| GB9709739D0 (en) | Pharmaceutical formulation | |
| HUP0003528A3 (en) | Pharmaceutical compositions containing dihydropolyprenols | |
| ZA96392B (en) | Pharmaceutical formulations | |
| SI0906101T1 (en) | Slow-release pharmaceutical formulations containing mizolastin | |
| GB9413542D0 (en) | Pharmaceutical formulations | |
| GB9500978D0 (en) | Pharmaceutical formulations | |
| GB9621531D0 (en) | Pharmaceutical formulations | |
| GB9606372D0 (en) | Pharmaceutical formulations | |
| GB9703607D0 (en) | Pharmaceutical formulations | |
| GB9603141D0 (en) | Pharmaceutical formulation | |
| GB9823192D0 (en) | Pharmaceutical formulations | |
| GB9813452D0 (en) | Pharmaceutical formulations | |
| GB9805931D0 (en) | Pharmaceutical formulations | |
| GB9828205D0 (en) | Pharmaceutical formulations | |
| GB9826392D0 (en) | Pharmaceutical formulations | |
| GB9807556D0 (en) | Pharmaceutical formulations | |
| GB9825117D0 (en) | Pharmaceutical formulations |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PF | Patent in force | ||
| CHPA | Change of a particular in the register (except of change of ownership) | ||
| PE | Patent expired |
Effective date: 20170227 |